|
1
|
Savarese G and Lund LH: Global public
health burden of heart failure. Card Fail Rev. 3:7–11.
2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Benjamin EJ, Muntner P, Alonso A,
Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR,
Cheng S, Das SR, et al: Heart disease and stroke statistics-2019
update: A report from the american heart association. Circulation.
139:e556–e528. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Yancy CW, Jessup M, Bozkurt B, Butler J,
Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi
JL, et al: 2013 ACCF/AHA guideline for the management of heart
failure: A report of the American college of cardiology
foundation/American heart association task force on practice
guidelines. J Am Coll Cardiol. 62:e147–e239. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Owan TE, Hodge DO, Herges RM, Jacobsen SJ,
Roger VL and Redfield MM: Trends in prevalence and outcome of heart
failure with preserved ejection fraction. N Engl J Med.
355:251–259. 2006.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Paul B, Soon KH, Dunne J and De Pasquale
CG: Diagnostic and prognostic significance of plasma
N-terminal-pro-brain natriuretic peptide in decompensated heart
failure with preserved ejection fraction. Heart Lung Circ.
17:497–501. 2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Geisler S and Coller J: RNA in unexpected
places: Long non-coding RNA functions in diverse cellular contexts.
Nat Rev Mol Cell Biol. 14:699–712. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Mattick JS and Rinn JL: Discovery and
annotation of long noncoding RNAs. Nat Struct Mol Biol. 22:5–7.
2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Shi Q and Yang X: Circulating MicroRNA and
long noncoding RNA as biomarkers of cardiovascular diseases. J Cell
Physiol. 231:751–755. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kumarswamy R, Bauters C, Volkmann I, Maury
F, Fetisch J, Holzmann A, Lemesle G, de Groote P, Pinet F and Thum
T: Circulating long noncoding RNA, LIPCAR, predicts survival in
patients with heart failure. Circ Res. 114:1569–1575.
2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Gao L, Liu Y, Guo S, Yao R, Wu L, Xiao L,
Wang Z, Liu Y and Zhang Y: Circulating long noncoding RNA HOTAIR is
an essential mediator of acute myocardial infarction. Cell Physiol
Biochem. 44:1497–1508. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wang F, Su X, Liu C, Wu M and Li B:
Prognostic value of plasma long noncoding RNA ANRIL for in-stent
restenosis. Med Sci Monit. 23:4733–4739. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Young TL, Matsuda T and Cepko CL: The
noncoding RNA taurine upregulated gene 1 is required for
differentiation of the murine retina. Curr Biol. 15:501–512.
2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ponikowski P, Voors AA, Anker SD, Bueno H,
Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP,
Jankowska EA, et al: 2016 ESC Guidelines for the diagnosis and
treatment of acute and chronic heart failure: The Task Force for
the diagnosis and treatment of acute and chronic heart failure of
the European Society of Cardiology (ESC)developed with the special
contribution of the heart failure association (HFA) of the ESC. Eur
Heart J. 37:2129–2200. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Elasfar A: Correlation between plasma
N-terminal pro-brain natriuretic peptide levels and changes in New
York Heart Association functional class, left atrial size, left
ventricular size and function after mitral and/or aortic valve
replacement. Ann Saudi Med. 32:469–472. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bhargava S, Ali A, Manocha A, Kankra M,
Das S and Srivastava LM: Homocysteine in occlusive vascular
disease: A risk marker or risk factor. Indian J Biochem Biophys.
49:414–420. 2012.PubMed/NCBI
|
|
17
|
Di Palo KE and Barone NJ: Hypertension and
heart failure: Prevention, targets, and treatment. Heart Fail Clin.
16:99–106. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Fitzgibbons TP, Meyer TE and Aurigemma GP:
Mortality in diastolic heart failure: An update. Cardiol Rev.
17:51–55. 2009.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Negi SI, Jeong EM, Shukrullah I, Raicu M
and Dudley SC Jr: Association of low plasma adiponectin with early
diastolic dysfunction. Congest Heart Fail. 18:187–191.
2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Poss J, Link A and Bohm M: Acute and
chronic heart failure in light of the new ESC guidelines. Herz.
38:812–820. 2013.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
21
|
Zou X, Wang J, Tang L and Wen Q: LncRNA
TUG1 contributes to cardiac hypertrophy via regulating miR-29b-3p.
In Vitro Cell Dev Biol Anim. 55:482–490. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Su Q, Liu Y, Lv XW, Dai RX, Yang XH and
Kong BH: LncRNA TUG1 mediates ischemic myocardial injury by
targeting miR-132-3p/HDAC3 axis. Am J Physiol Heart Circ Physiol.
318:H332–H344. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li FP, Lin DQ and Gao LY: LncRNA TUG1
promotes proliferation of vascular smooth muscle cell and
atherosclerosis through regulating miRNA-21/PTEN axis. Eur Rev Med
Pharmacol Sci. 22:7439–7447. 2018.PubMed/NCBI View Article : Google Scholar
|
